Search Results 211-220 of 5981 for albumin

  1. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    Serum albumin <2.5 g/dL at baseline; CMV polymerase chain reaction (PCR) positive from blood plasma at screening; Known stool studies positive for ova and/or ...

  2. Mayo Clinic Q & A - Dr. John Weroha - Ovarian cancer

    So, albumin reflects the nutritional status. And if that is too low, then that patient has really high risk for a bad outcome and will probably not have surgery ...

  3. A Study to Evaluate Pevonedistat, Azacitidine (or Decitabine), and Venetoclax (PAVE) to Treat Acute Myelogenous Leukemia (AML) Patients - Mayo Clinic

    Albumin > 2.7 g/dL; · Total bilirubin ≤ institutional upper limit of normal (ULN). · Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 × ...

  4. Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Serum albumin < 2.5 g/dL; Serum creatinine > 1.5× ULN (or a calculated creatinine clearance < 60 mL/min/1.73 m2). Patients with a significant cardiovascular ...

  5. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

    Adequate renal and liver function as indicated by serum creatinine ≤ 1.0 x ULN or creatinine clearance of > 60 cc/min, serum albumin ≥ 3.0 gm/dL, total ...

  6. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

    Serum albumin ≥ g/dL;; Amylase and lipase ≤.5× ULN (≤× ULN if amylase or lipase is isolated with neitherclinical nor radiographic signs of pancreatitis) ...

  7. Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer - Mayo Clinic

    Albumin ≥ 2.0 g/dL; Neutrophil count >1200/mm³ (1.2x10⁹/L). Exclusion Criteria: History of hepatic encephalopathy; Contraindications to angiography and ...

  8. Study of SBP-101 in Pancreatic Cancer - Mayo Clinic

    Serum albumin <30 g/L (3.0 g/dL); Glycosylated hemoglobin (Hgb A1C) > 8.0%; Life expectancy <16 weeks; Presence of known active bacterial, fungal, or viral ...

  9. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    Albumin ≥2.5 g/dL during screening; Serum creatinine ≤1.5 mg/dL during screening. Exclusion Criteria: Evidence of severe decompensation. Non-cirrhotic ...

  10. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

    The purpose of phase 2a is to establish proof-of-concept (POC) for AG-946 in participants with lower-risk myelodysplastic syndromes (LR-MDS) and to evaluate the ...